JPIAMR 14th Call: Disrupting Drug Resistance Using Innovative Design
ERA PerMed – JTC 2022: “Prevention in Personalised Medicine”
5 enero, 2022
¿Me tengo que hacer una prueba antes de vacunarme contra la covid?
11 enero, 2022The call Disrupting drug resistance using innovative design has been launched within the framework of the ERA-NET JPIAMR-ACTION and will involve 26 funding organisations from 17 countries. The total estimated call budget is 17 million Euro.
Proposals should focus on licenced antimicrobial agents (antibiotics/antifungals) or agents under pre-clinical and/or early clinical development.
Funding organisation in Spain: National Institute of Health Carlos III (ISCIII) and Agencia Estatal de Investigacion (AEI).
Webinar for applicants: JPIAMR is pleased to invite researchers to a live webinar on the 25th of January 2022 presenting the call and the partner search tool. Representatives from funders participating in the call will be available to answer questions. Read more and register to the webinar
Deadline for preproposal: 08/03/2022.
Deadline for full proposal: 05/07/2022.